Revvity

Revvity, Inc. is an American company dedicated to revolutionizing health science through innovative solutions in life sciences and diagnostics. Born from the legacy of PerkinElmer, Revvity was officially established on May 9, 2023, following a corporate split that allowed for a focus on the life sciences and diagnostics sectors. The name 'Revvity' is derived from the words 'revolution' and 'vita,' symbolizing our commitment to transforming healthcare outcomes. We serve as a comprehensive partner to pharmaceutical and biotechnology companies, providing them with advanced workflows from research and discovery to clinical testing and market strategies.

With a workforce of over 11,000 employees across 190 countries, Revvity leverages a vast network of talent to deliver custom solutions that enhance patient outcomes and address critical health challenges worldwide. Our approach incorporates cutting-edge technologies in multi-omics, biomarker identification, and informatics, ensuring that our clients receive the most innovative tools tailored to their needs. As we look to the future, Revvity is poised to lead the next wave of advancements in healthcare, committed to making high-quality health solutions accessible to all. We believe in the power of collaboration and are dedicated to influencing the future of health science by overcoming barriers and expanding the boundaries of human potential.